Purple Biotech Ltd. (PPBT) Financials

PPBT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 44.3 million 10.0 million
2023-09-30 45.3 million 6.6 million
2023-06-30 48.0 million 5.3 million
2023-03-31 53.1 million 6.0 million

PPBT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -4.9 million 181000
2023-09-30 -3.7 million 449000
2023-06-30 -5.2 million 493000
2023-03-31 -6.1 million 752000

PPBT Net Income

No data available :(

PPBT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 15.4 million - 351000
2023-09-30 16.1 million - 370000
2023-06-30 - - 421000
2023-03-31 23.1 million - 467000

PPBT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 24.6 million
2023-09-30 21.8 million
2023-06-30 209.4 million
2023-03-31 19.8 million

PPBT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 5.2 million 630000 -
2023-09-30 1000 4.6 million 1.2 million -
2023-06-30 1000 3.7 million 1.4 million -
2023-03-31 3000 3.5 million 1.6 million -

PPBT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 48000
2023-09-30 - 50000
2023-06-30 - -
2023-03-31 - 46000

PPBT

Price: $0.53

52 week price:
0.41
2.16

Earnings Per Share: -0.90 USD

P/E Ratio: -0.78

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 20300

Market Capitalization: 16.0 million

Links: